Neurocrine Biosciences Inc at Needham Neuroscience Forum (Virtual) Transcript
Good afternoon, everyone. Welcome to the next session with Neurocrine Bioscience. Kyle, thank you so much for taking out the time to join today.
For those who are not very familiar with the company and with Kyle, Kyle is the Chief Business Development and Strategy Officer at Neurocrine. He's been with the company since 2011 and has been responsible for many of the business development collaborations that the company has and would love to spend the session that we have with Kyle to go over some of the many pipeline initiatives that the company is undertaking. But perhaps before we start, if I could ask Kyle to just give us some opening remarks, and we'll jump right into questions. And the audience can send me questions via the chat as well.
Great. Thanks, Ami, and welcome to everyone here for the conference. It's a great lineup today. I'm just going over the agenda. It looks like a full
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |